A Long-Overdue Reset: The FDA’s HRT Label Change
December 5, 2025
Conversations about hormone replacement therapy (HRT) have carried a degree of hesitation for many years – on both sides of the exam table. That’s largely because FDA black box warnings broadly framed hormone therapy as high-risk, despite growing evidence to the contrary. The FDA’s recent decision to remove those warnings doesn’t signal a sudden endorsement […]
